Sharzad Emamikia

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.

Journal: Lupus
Published: March 28, 2024

Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.

Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.

Journal: Frontiers in medicine
Published: June 26, 2023

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.

Journal: Rheumatology (Oxford, England)
Published: January 24, 2023

EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.

EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.

Journal: Frontiers in medicine
Published: November 07, 2022

How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

Journal: Journal of clinical medicine
Published: January 30, 2022

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)
Published: November 30, 2021

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.

Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.

Journal: Frontiers in medicine
Published: January 09, 2021

EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.

EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)
Published: October 14, 2020

Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.

Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.

Journal: Rheumatology (Oxford, England)
Published: October 05, 2020

Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.

Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.

Journal: Journal of clinical medicine
Published: May 14, 2020

Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)
Published: April 22, 2020

Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trials.

Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trials.

Journal: The Lancet. Rheumatology
Published: July 12, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026